Sandostatin LAR Depot and Ustekinumab Intravenous Infusion
Determining the interaction of Sandostatin LAR Depot and Ustekinumab Intravenous Infusion and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Sandostatin LAR Depot (injection)
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Sandostatin LAR Depot-Ustekinumab Subcutaneous
- Sandostatin LAR Depot-Ustekinumab Subcutaneous Injection
- Sandostatin LAR Depot-Ustell
- Sandostatin LAR Depot-UTA
- Sandostatin LAR Depot-UTA Capsules
- Sandostatin LAR Depot-UTAC tablets
- Ustekinumab Intravenous Infusion-Sandostatin LAR Depot injection
- Ustekinumab Intravenous Infusion-Sani-Supp
- Ustekinumab Intravenous Infusion-Sani-Supp rectal
- Ustekinumab Intravenous Infusion-Sansert
- Ustekinumab Intravenous Infusion-Santyl
- Ustekinumab Intravenous Infusion-Saphris